butabarbital decreases results of sufentanil SL by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Keep track of Carefully. Coadministration of CYP3A4 inducers may perhaps minimize sufentanil amounts and efficacy, perhaps precipitating withdrawal syndrome in individuals which h